Avanti Polar Lipids part of Croda International Plc

As the Lipid Technology segment of Croda Pharma, part of the Life Science sector of Croda Inc., Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology or drug products. For over 30 years, Avanti Polar Lipids has supported and been involved in gene therapy research. Through our manufacturing of high-purity lipids for nucleic acid delivery, we have facilitated clinical development of novel vaccines and therapeutics. We will summarize the path that put Avanti at the forefront of the Race to Beat COVID-19.